Suppr超能文献

[妇科手术后肠道无张力的治疗。蛙皮素有效性及耐受性研究]

[Treatment of intestinal atony following gynecologic operations. Study on the effectiveness and tolerance of ceruletide].

作者信息

von Fournier D, Baur M, Schmid H, Schulz-Wendtland R, Heinrich D, Kubli F

出版信息

Fortschr Med. 1984 Jul 26;102(27-28):740-2.

PMID:6383991
Abstract

The efficacy and tolerability of Ceruletide and Neostigmin were compared in patients with postoperative intestinal atonia after extensive gynecological surgical operations. Patients treated with Ceruletide (n = 30, dosage of Ceruletide 2 ng/kg/min. i.v.) showed earlier defecation than the Neostigmin-group (n = 30, dosage of neostigmin 3 x 0,5 mg/die). The frequency of side effects was comparable in both groups, patients treated with Ceruletide suffered mainly from gastrointestinal symptoms (nausea) whereas patients treated with Neostigmin complained of disorders of circulation. Ceruletide is faster effective than Neostigmin, the tolerability of both drugs is equivalent.

摘要

在接受广泛妇科手术后发生术后肠道无力的患者中,比较了赛鲁肽和新斯的明的疗效及耐受性。接受赛鲁肽治疗的患者(n = 30,赛鲁肽静脉注射剂量为2 ng/kg/分钟)比新斯的明组(n = 30,新斯的明剂量为每日3次,每次0.5 mg)排便更早。两组的副作用发生率相当,接受赛鲁肽治疗的患者主要出现胃肠道症状(恶心),而接受新斯的明治疗的患者则抱怨有循环系统紊乱。赛鲁肽比新斯的明起效更快,两种药物的耐受性相当。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验